ClinicalTrials.Veeva

Menu

Interference by Activated Protein C Resistance in the Determination of Protein S Activity (PS)

U

University Hospital, Strasbourg, France

Status

Enrolling

Conditions

Resistance to Activated Protein C in the Determination of Protein S Activity

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Protein S is an anticoagulant protein and a cofactor of protein C. It is recommended to explore it first by a functional (chronometric) technique by assessing its cofactor activity of activated protein C. Existing tests measure the prolongation of a coagulation time. These tests are all dependent on factor V, but some patients have mutations in factor V (including V Leiden) that make them resistant to activated protein C activity. It is suspected that these mutations lead to underestimations of protein S activity by chronometric technique.

Enrollment

9,470 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient of legal age (≥ 18 years)
  • Patient for whom a sample has been sent to the HUS Hematology Laboratory for measurement of protein S activity between 28/12/2009 and 29/12/2020
  • Patient who does not object to the reuse of his/her medical data for scientific research purposes.

Exclusion criteria

  • Minor patient
  • Patient with incomplete data

Trial contacts and locations

1

Loading...

Central trial contact

Agathe HERB, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems